Valuence Merger Corp. I
VMCAU
NASDAQ Global Market11.37
USD
- -
- -
CIK
0001892747
ISIN
KYG9R16L1263
CUSIP
G9R16L126
Return %
Stock
S&P500
1Y
-0.70
18.21
3Y
13.13
64.38
5Y
13.70
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Sung Yoon Woo
- Full Time Employees
- 4
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 4 Orinda Way Orinda CA United States of America 94563
- IPO Date
- Mar 1, 2022
- CIK
- 0001892747
- Website
- valuencecap.com
- Similar Companies
- Business
- Valuence Merger Corp. I operates as a blank check company, or special purpose acquisition company (SPAC), with no current significant operations other than seeking to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses. Incorporated in 2021 and headquartered at 4 Orinda Way, Suite 100D, Orinda, California 94563, the company focuses on targets in Asia (excluding China, Hong Kong and Macau) that develop breakthrough technology in life sciences or advance platforms for sustainable technology; its securities trade on Nasdaq under the tickers VMCA (Class A ordinary shares), VMCAU (units) and VMCAW (warrants). It priced a $200 million initial public offering in March 2022, began separate trading of its ordinary shares and warrants in April 2022, and maintains a trust account for potential redemptions pending completion of an initial business combination. The company offers investors units comprising one Class A ordinary share and one-half of one redeemable warrant, each whole warrant exercisable for one Class A ordinary share at $11.50; upon separation, shares and warrants trade independently while units may continue to trade. Valuence Merger Corp. I targets institutional and accredited investors interested in public market exposure to pre-IPO Asian sustainable and life sciences innovators through a de-SPAC transaction, with operations centered in the United States and prospective merger activity in Asia. In recent developments, the company has pursued multiple monthly extensions of its initial business combination deadline, including from December 3, 2024, to January 3, 2025 (the fifth of up to 19 possible extensions), from March 3, 2025, to April 3, 2025, and ongoing efforts into mid-2025 without announcing a specific target; each extension includes a $28,011 deposit into its trust account. It issued annual PFIC information statements for 2022 through 2024 and held an extraordinary general meeting, reflecting continued compliance and shareholder engagement amid prolonged target search. As of late 2025, no merger has been consummated, with the deadline extendable to March 2026 under its amended governing documents.
Valuence Merger Corp. I Announces Adjournment of Shareholder Meeting to Approve an Extension
Valuence Merger Corp. I Announces Adjournment of Shareholder Meeting to Approve an Extension